Impact of prescription drug-monitoring program on controlled substance prescribing in the ED

Matthew W. McAllister, Patrick Aaronson, Joe Spillane, Mark Schreiber, Genelyn Baroso, Dale Kraemer, Carmen Smotherman, Kelly Gray-Eurom

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Objective In 2009, Florida initiated a statewide prescription drug-monitoring program (PDMP) to encourage safer prescribing of controlled substances and reduce drug abuse and diversion. Data supporting the utility of such programs in the emergency department (ED) is scarce. This study sought to determine the effect of PDMP data on controlled substance prescribing from the ED. Methods In this pre-post study utilizing a historical control, pharmacists in the ED provided prescribers with a summary of the PDMP data for their patients. The number of controlled substances prescribed in the intervention group was compared with that prescribed in the historical control to determine if the intervention resulted in a change in the average number of controlled substance prescribed. Results Among the 710 patients evaluated, providing prescribers with PDMP data did not alter the average number of controlled substance per patient prescribed (0.23 controlled substances per patient in the historical control compared with 0.28 controlled substances per patient in the intervention group; 95% confidence interval [CI], - 0.016 to 0.116; P =.125). All prescribers surveyed indicated that having PDMP data altered their controlled substance prescribing and felt more comfortable prescribing controlled substances. Conclusions Although the results did not demonstrate a change in the average number of controlled substances prescribed when prescribers were provided with PDMP data, results from the survey indicate that prescribers felt the data altered their prescribing of controlled substances, and thus were more contented prescribing controlled substances.

Original languageEnglish (US)
Pages (from-to)781-785
Number of pages5
JournalAmerican Journal of Emergency Medicine
Volume33
Issue number6
DOIs
StatePublished - Jan 1 2015
Externally publishedYes

Fingerprint

Controlled Substances
Prescription Drugs
Drug Monitoring
Hospital Emergency Service
Pharmacists
Substance-Related Disorders

ASJC Scopus subject areas

  • Emergency Medicine

Cite this

Impact of prescription drug-monitoring program on controlled substance prescribing in the ED. / McAllister, Matthew W.; Aaronson, Patrick; Spillane, Joe; Schreiber, Mark; Baroso, Genelyn; Kraemer, Dale; Smotherman, Carmen; Gray-Eurom, Kelly.

In: American Journal of Emergency Medicine, Vol. 33, No. 6, 01.01.2015, p. 781-785.

Research output: Contribution to journalArticle

McAllister, MW, Aaronson, P, Spillane, J, Schreiber, M, Baroso, G, Kraemer, D, Smotherman, C & Gray-Eurom, K 2015, 'Impact of prescription drug-monitoring program on controlled substance prescribing in the ED', American Journal of Emergency Medicine, vol. 33, no. 6, pp. 781-785. https://doi.org/10.1016/j.ajem.2015.03.036
McAllister, Matthew W. ; Aaronson, Patrick ; Spillane, Joe ; Schreiber, Mark ; Baroso, Genelyn ; Kraemer, Dale ; Smotherman, Carmen ; Gray-Eurom, Kelly. / Impact of prescription drug-monitoring program on controlled substance prescribing in the ED. In: American Journal of Emergency Medicine. 2015 ; Vol. 33, No. 6. pp. 781-785.
@article{49ccaef673a54f12ae9be01e66a10878,
title = "Impact of prescription drug-monitoring program on controlled substance prescribing in the ED",
abstract = "Objective In 2009, Florida initiated a statewide prescription drug-monitoring program (PDMP) to encourage safer prescribing of controlled substances and reduce drug abuse and diversion. Data supporting the utility of such programs in the emergency department (ED) is scarce. This study sought to determine the effect of PDMP data on controlled substance prescribing from the ED. Methods In this pre-post study utilizing a historical control, pharmacists in the ED provided prescribers with a summary of the PDMP data for their patients. The number of controlled substances prescribed in the intervention group was compared with that prescribed in the historical control to determine if the intervention resulted in a change in the average number of controlled substance prescribed. Results Among the 710 patients evaluated, providing prescribers with PDMP data did not alter the average number of controlled substance per patient prescribed (0.23 controlled substances per patient in the historical control compared with 0.28 controlled substances per patient in the intervention group; 95{\%} confidence interval [CI], - 0.016 to 0.116; P =.125). All prescribers surveyed indicated that having PDMP data altered their controlled substance prescribing and felt more comfortable prescribing controlled substances. Conclusions Although the results did not demonstrate a change in the average number of controlled substances prescribed when prescribers were provided with PDMP data, results from the survey indicate that prescribers felt the data altered their prescribing of controlled substances, and thus were more contented prescribing controlled substances.",
author = "McAllister, {Matthew W.} and Patrick Aaronson and Joe Spillane and Mark Schreiber and Genelyn Baroso and Dale Kraemer and Carmen Smotherman and Kelly Gray-Eurom",
year = "2015",
month = "1",
day = "1",
doi = "10.1016/j.ajem.2015.03.036",
language = "English (US)",
volume = "33",
pages = "781--785",
journal = "American Journal of Emergency Medicine",
issn = "0735-6757",
publisher = "W.B. Saunders Ltd",
number = "6",

}

TY - JOUR

T1 - Impact of prescription drug-monitoring program on controlled substance prescribing in the ED

AU - McAllister, Matthew W.

AU - Aaronson, Patrick

AU - Spillane, Joe

AU - Schreiber, Mark

AU - Baroso, Genelyn

AU - Kraemer, Dale

AU - Smotherman, Carmen

AU - Gray-Eurom, Kelly

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Objective In 2009, Florida initiated a statewide prescription drug-monitoring program (PDMP) to encourage safer prescribing of controlled substances and reduce drug abuse and diversion. Data supporting the utility of such programs in the emergency department (ED) is scarce. This study sought to determine the effect of PDMP data on controlled substance prescribing from the ED. Methods In this pre-post study utilizing a historical control, pharmacists in the ED provided prescribers with a summary of the PDMP data for their patients. The number of controlled substances prescribed in the intervention group was compared with that prescribed in the historical control to determine if the intervention resulted in a change in the average number of controlled substance prescribed. Results Among the 710 patients evaluated, providing prescribers with PDMP data did not alter the average number of controlled substance per patient prescribed (0.23 controlled substances per patient in the historical control compared with 0.28 controlled substances per patient in the intervention group; 95% confidence interval [CI], - 0.016 to 0.116; P =.125). All prescribers surveyed indicated that having PDMP data altered their controlled substance prescribing and felt more comfortable prescribing controlled substances. Conclusions Although the results did not demonstrate a change in the average number of controlled substances prescribed when prescribers were provided with PDMP data, results from the survey indicate that prescribers felt the data altered their prescribing of controlled substances, and thus were more contented prescribing controlled substances.

AB - Objective In 2009, Florida initiated a statewide prescription drug-monitoring program (PDMP) to encourage safer prescribing of controlled substances and reduce drug abuse and diversion. Data supporting the utility of such programs in the emergency department (ED) is scarce. This study sought to determine the effect of PDMP data on controlled substance prescribing from the ED. Methods In this pre-post study utilizing a historical control, pharmacists in the ED provided prescribers with a summary of the PDMP data for their patients. The number of controlled substances prescribed in the intervention group was compared with that prescribed in the historical control to determine if the intervention resulted in a change in the average number of controlled substance prescribed. Results Among the 710 patients evaluated, providing prescribers with PDMP data did not alter the average number of controlled substance per patient prescribed (0.23 controlled substances per patient in the historical control compared with 0.28 controlled substances per patient in the intervention group; 95% confidence interval [CI], - 0.016 to 0.116; P =.125). All prescribers surveyed indicated that having PDMP data altered their controlled substance prescribing and felt more comfortable prescribing controlled substances. Conclusions Although the results did not demonstrate a change in the average number of controlled substances prescribed when prescribers were provided with PDMP data, results from the survey indicate that prescribers felt the data altered their prescribing of controlled substances, and thus were more contented prescribing controlled substances.

UR - http://www.scopus.com/inward/record.url?scp=84930924933&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930924933&partnerID=8YFLogxK

U2 - 10.1016/j.ajem.2015.03.036

DO - 10.1016/j.ajem.2015.03.036

M3 - Article

VL - 33

SP - 781

EP - 785

JO - American Journal of Emergency Medicine

JF - American Journal of Emergency Medicine

SN - 0735-6757

IS - 6

ER -